Jun 2026 (Q2 FY26) — Aug 6, 2026
National Healthcare Properties Q2 FY26 — Strong SHOP Growth & Strategic Portfolio Reorientation
Read the full callNational Healthcare Properties earnings: last reported Thu, 6 Aug 2026, for the quarter ended Jun 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 87.5 | +2.6% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 5.8 | +12.3 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | Quarterly, as filed | Quarter to Jun 2026 | Not in the filed figures for the quarter to jun 2026. No older figure is substituted. |
Price
YTD: $12 on 22 Apr 2026 → $14.81. High $17.08 (20 Aug 2026), low $12 (22 Apr 2026).
Overview
Call summaries
National Healthcare Properties Q2 FY26 — Strong SHOP Growth & Strategic Portfolio Reorientation
Read the full callEvery analysed call
Financials
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 89 | 88 | 86 | 85 | 86 | 84 | 86 | 88 |
| Operating profit | -21 | -1 | 13 | -6 | 2 | -7 | 10 | 5 |
| Operating margin | −23.5% | −1.2% | 15.1% | −6.5% | 2.8% | −7.8% | 11.7% | 5.8% |
| Other income | -20 | -16 | -15 | -15 | -15 | -16 | -14 | -10 |
| Interest | 18 | 17 | 15 | 16 | 15 | 16 | 15 | 13 |
| Profit before tax | -41 | -17 | -2 | -21 | -12 | -23 | -4 | -5 |
| Tax rate | 0.0% | −0.8% | 0.4% | 0.0% | −0.5% | −0.4% | −1.8% | −0.9% |
| EPS ($ per share) | -1.56 | — | -0.18 | -0.85 | -0.56 | — | -0.27 | -0.13 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reserves | -804 | -971 | -1,109 | -1,283 | -1,462 | — | — | — |
| Total liabilities | 1,137 | 1,219 | 1,326 | 1,174 | 1,181 | 1,245 | 1,256 | 1,107 |
| Total assets | 2,377 | 2,325 | 2,287 | 2,214 | 2,180 | 2,145 | 1,946 | 1,712 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 54 | 47 | 42 | 39 | 28 | 22 | -80 | 7 |
| Cash from investing | -115 | -46 | -82 | -48 | -42 | -63 | 64 | 70 |
| Cash from financing | 50 | 19 | 19 | 4 | 5 | 56 | -1 | -42 |
| Net cash flow | -11 | 20 | -21 | -5 | -9 | 15 | -17 | 34 |
| Capital expenditure | -13 | -17 | -117 | -178 | -54 | -58 | -28 | -29 |
| Free cash flow | 41 | 31 | -75 | -139 | -25 | -36 | -107 | -22 |
3 filings between Apr 30, 2026 and Sep 27, 2026.
Nobody bought or sold NHP on the open market in this window. The filings below are 2 awards and 1 tax withheld.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 27, 2026 | Anderson Michael Ray CEO, President & director | Tax withheld | 16,041 | $257.1K |
| Aug 17, 2026 | Campbell Albert M III Director | Award | 4,693 | $0 |
| Apr 30, 2026 | Rendell Edward G Director | Award | 12,500 | $0 |
| Sep 27, 2025 | Anderson Michael Ray CEO, President & director | Tax withheld | 19,041 | $612.2K |
| May 23, 2025 | Tuppeny Elizabeth K. Director | Award | 3,110 | $0 |
| May 23, 2025 | Weil Edward M Jr. Director | Award | 3,110 | $0 |
| May 23, 2025 | Anderson Michael Ray CEO, President & director | Award | 90,201 | $0 |
| May 23, 2025 | Lappetito Scott M. CFO & Treasurer | Award | 43,545 | $0 |
| May 23, 2025 | MICHELSON LESLIE D Director | Award | 3,110 | $0 |
| May 23, 2025 | Rendell Edward G Director | Award | 3,110 | $0 |
| May 23, 2025 | Penn Buddie J Director | Award | 3,110 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow National Healthcare Properties, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading